Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.34 |
| ▸ | PPARG | P37231 | 3/20 | 0.34 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | RXRA | P19793 | 2/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.34 |
| ▸ | PPARA | Q07869 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.33 |
| ▸ | F7 | P08709 | 3/20 | 0.32 |
| ▸ | F3 | P13726 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | PPARD | Q03181 | 2/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3684904 | 1.00 | ALDH1A1 (0.34) | ALDH1A1LMNACYP19A1PPARGOXER1 | |
| SCHEMBL3692059 | 0.96 | ALDH1A1 (0.40) | ALDH1A1LMNACYP19A1PPARGOXER1 | |
| SCHEMBL2875209 | 0.83 | ALDH1A1 (0.37) | ALDH1A1LMNACYP19A1PPARGOXER1 | |
| SCHEMBL3694814 | 0.83 | ALDH1A1 (0.37) | ALDH1A1LMNACYP19A1PPARGOXER1 | |
| SCHEMBL3694816 | 0.83 | ALDH1A1 (0.37) | ALDH1A1LMNACYP19A1PPARGOXER1 | |
| SCHEMBL3695647 | 0.83 | ALDH1A1 (0.37) | ALDH1A1LMNACYP19A1PPARGOXER1 | |
| SCHEMBL3694031 | 0.82 | ALDH1A1 (0.41) | ALDH1A1LMNACYP19A1PPARGOXER1 | |
| SCHEMBL3692853 | 0.82 | ALDH1A1 (0.41) | ALDH1A1LMNACYP19A1PPARGOXER1 | |
| SCHEMBL11890118 | 0.80 | GRIK1 (0.36) | ALDH1A1LMNA | |
| SCHEMBL11890117 | 0.80 | GRIK1 (0.36) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2187748-A2 | FUNGICIDAL COMPOUNDS AND MIXTURES | E. I. du Pont de Nemours and Company (US) | 2010-05-26 | — | — | EP | claimed |
| WO-2009055514-A2 | FUNGICIDAL MIXTURES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-04-30 | — | — | WO | claimed |
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-09-23 | — | — | US | disclosed |
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-09-23 | — | — | US | disclosed |
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-09-23 | — | — | US | disclosed |
| EP-2129646-A2 | OMEGA-3 LIPID COMPOUNDS | Pronova Biopharma Norge AS (NO) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008132552-A2 | OMEGA-3 LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (US) | 2008-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | ELOVL3, FFAR3, STARD3 | ALDH1A1 2317/4885LMNA 424/4885CYP19A1 1573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.